Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00232440|
Recruitment Status : Completed
First Posted : October 4, 2005
Last Update Posted : August 11, 2010
Radiation therapy has a well-established role in the treatment of Hodgkin's Disease and non-Hodgkin's Lymphoma. With technological developments, 3-D Dimensional (3D) planning has evolved as a highly precise treatment planning option. High-precision radiation therapy has the potential for more accurate dose delivery to the tumour volume and can result in a greater sparing of normal tissue. An important component of safe radiotherapy delivery is the feasibility and reproducibility of current and new immobilization devices for highly conformal treatment.
The purpose of this study is to determine the reproducibility of an immobilization device known as BodyFIX(TM) using conventional treatment techniques.
|Condition or disease||Intervention/treatment||Phase|
|Hodgkin's Disease Lymphoma, Non-Hodgkin||Device: BodyFIX||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|
|Study Start Date :||January 2003|
|Actual Primary Completion Date :||June 2009|
|Actual Study Completion Date :||June 2009|
- The primary outcome for the study is the average deviation in set-up.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00232440
|University Health Network|
|Toronto, Ontario, Canada, M5G 2M9|
|Principal Investigator:||Alex Sun, MD||Princess Margaret Hospital, Canada|